ClinicalTrials.gg
RecruitingNCT06083090YOKISPAUpdated Oct 1, 2025

Effects of Yoga Therapy in Rehabilitation Compared to Physiotherapy in Moderate Axial Spondyloarthritis (axSPA)

An interventional study of Yogatherapy and Physiotherapy in Axial Spondyloarthritis (axSPA), sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 5 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2024; still recruiting 2 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Axial Spondyloarthritis with a site in France — 9 open to participants now, 11 under way, 3 of them phase 3. Axial Spondyloarthritis · France.

Planned enrollment
24th of 30
72 · median 188
Started
2024
with 3 others
No phase
13 of 40
6 open now
Primary completion
2028-02
later than 7 of 10 live
Registered
35th of 40
by date
Lead sponsor
7 of 40
Assistance Publique - Hôpitaux de Paris

Among the 40 studies in Axial Spondyloarthritis with a site in France, this one is the 24th largest by planned enrollment of the 30 interventional ones that give a count, is one of 4 that started in 2024, is one of 13 with no phase, reaches primary completion later than 7 of the 10 other live ones, and was the 35th registered.

Axial Spondyloarthritis

187 studies on the registry are indexed under Axial Spondyloarthritis; 57 are open to participants now.

Browse Axial Spondyloarthritis studies →

Open to participants now

9 of the 40 studies in Axial Spondyloarthritis with a site in France are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 39 Axial Spondyloarthritis studies recruiting now, 20 (51%) set no upper age limit and 13 (33%) stop at 75 or younger; 5 take children under 18; 3 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Axial Spondyloarthritis with a site in France, or all of them as a file.
02

Study summary

A few studies have evaluated the effectiveness of yoga therapy in patients with axial spondyloarthritis (axSPA). On the other hand, studies conducted in other chronic rheumatisms such as low back pain, rheumatoid arthritis or other conditions such as cancer have shown that yogatherapy can have a effective action on the physical and psychological level.

Yogatherapy is a non-drug "body-mind" approach that would be likely to improve the physical symptoms (pain, stiffness, in particular spinal and pelvic), internal organs (colitis) and psychological symptoms as well as the perception of fatigue of people with axSPA. A 2021 study showed the feasibility and acceptability of regular yogatherapy practice in patients with axSPA.

It is therefore necessary to conduct randomized controlled studies to assess the effectiveness of this management strategy.

Read the detailed description

The term axial spondyloarthritis (axSPA) encompasses various inflammatory diseases of the spine, including ankylosing spondyloarthritis (AS) and non-radiographic axial spondyloarthritis (nr-axSPA).

axSPA is a chronic inflammatory joint disease affecting the axial skeleton. It is the second cause of chronic inflammatory rheumatism and affects 0.5 to 2% of the general population. It generally affects young adults, with a male predominance (2 men for 1 woman).

axSPA can lead to physical consequences (fatigue, pain, stiffness, with in particular serious damage to the spine causing functional impairment, etc.) and psychological consequences (anxiety, depression). It is responsible for a disability and a mediocre quality of life with, moreover, a significant socio-economic impact. In France, it is one of the long-term illnesses and may require heavy treatment.

The medicinal therapeutic side, taken care of by rheumatologists specializing in this pathology, has evolved a lot (from non-steroidal anti-inflammatory drugs [NSAIDs] to anti-tumor necrosis factor [anti-TNF] and anti-interleukin 17 [anti-IL 17]), allowing notable improvements. It is now a question of also developing the non-drug therapeutic side, to contribute to improving the quality of life, thus meeting the demand of patients with chronic diseases.

Information and therapeutic education occupy an important place, with results in favor of an improvement in the management of these diseases.

The recommendations emphasize that the non-pharmacological treatment of axSPA should include regular physical exercise, that individual and group physical therapy sessions should be considered as well as self-exercises.

Several randomized controlled trials have shown that physical therapy with various modalities has positive effects on pain and AS function. Physical therapy therefore also seems to play an important role in the management of patients. It prevents stiffness and improves functional capacity and quality of life.

Physical therapy should be initiated as soon as axSPA is diagnosed and regular exercise should form the basis of management. The review by Zochling et al. as well as a systematic review showed that exercises have positive effects on BASFI, BASDAI functions, pain and mobility. A Cochrane review on the role of physiotherapy interventions in SPA also concluded that physical therapy was beneficial. Physical activity, self-exercises and physiotherapy are part of the 2022 recommendations of the French Society of Rheumatology. Beneficial effects on disease activity were observed in axSPA, with good tolerance for intense exercise.

Recently an Indian team evaluated the effectiveness of online yogatherapy with 60 min structured modules on patients with axSPA for 3 months, with a significant improvement in the BASDAI score.

03

Conditions studied

  • Axial Spondyloarthritis (axSPA)

Keywords

  • Yogatherapy
  • Ankylosing Spondyloarthritis
  • Physiotherapy
  • Yoga
  • Rheumatism
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • French-speaking patient aged 18 and over
  • Patient with axial spondyloarthritis (axSPA) according to Assessment of SpondyloArthritis International Society, diagnosed by a rheumatologist
  • "Moderately active" to "active" form of axSPA (basic BASDAI > 3)
  • Stable disease: No recent or foreseeable introduction in the next 6 months of drug treatments for axSPA (excluding analgesics)
  • Absence of disabling stress urinary incontinence
  • Geographical or organizational possibility of undergoing the study
  • Patient informed and having signed the form for participation in the research

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding
  • Recent childbirth (within the last six months)
  • Patient already practicing yoga or having practiced it in the last six months
  • Abdominal or spinal surgery in the last six months
  • Motor neurological deficit
  • Sphincter deficit
  • Any other somatic pathology preventing the practice of physiotherapy or yogatherapy according to the opinion of the evaluating clinician
  • Depressive syndrome requiring specific treatment
  • Non-affiliation to a social security scheme (beneficiary or beneficiary) or to another social protection scheme
  • Patient deprived of liberty by judicial or administrative decision or under legal protection (guardianship, safeguard of justice)
  • Currently participating in or in a period of exclusion from: another interventional research involving human participants, a clinical trial on a medical product for human, a clinical investigation on a medical device. Participation in non-interventional research is authorized.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Yogatherapy

    Randomization of 36 patients in the yogatherapy group.

    Procedure: Yogatherapy

  • Active comparator
    Physiotherapy

    Randomization of 36 patients in the physiotherapy group.

    Procedure: Physiotherapy

Interventions

  • ProcedureYogatherapy

    The experimental arm will benefit from support by a physiotherapist trained in yoga, in a group for ten weeks with two weekly sessions of approximately 1 hour each. A new yoga program adapted for the axSPA will be implemented.

  • ProcedurePhysiotherapy

    The comparator arm will benefit from support by a physiotherapist, in groups for ten weeks at the rate of two weekly sessions of approximately 1 hour each. An already existing program adapted for the axSPA will be implemented.

06

What researchers measure

Primary outcomes

  1. Evolution of the axSPA global activity score (fatigue, pain, stiffness)

    Change in the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score, via a self-administered questionnaire that assesses the "activity" of the disease (6 items, max score = 100, the higher the score the more disabling the disease).

    Time frame: Between the 2 month visit and the 5 month visit.

Secondary outcomes

  1. Evolution of the axSPA global activity score (fatigue, pain, stiffness)

    Change in the BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) score, via a self-administered questionnaire that assesses the "activity" of the disease (6 items, max score = 100, the higher the score the more disabling the disease).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  2. Functional impact

    Change in self-assessment of functional capacity during daily tasks via the BASFI score (Bath Ankylosing Spondylitis disease Functional Index) (10 items, max score = 10, the higher the score the more disabling the disease).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  3. Health-related quality of life

    Change in the patient's self-assessment via the generic SF-36 scale (Short Form-36 scale) (36 items, max score = 100, the higher the score the better the perception of quality of life).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  4. Anxiety and depression

    Change in the patient's self-assessment via the HAD scale (Hospital Anxiety and Depression scale) (14 items, max anxiety score = 21, max depression score = 21, the higher the score the more anxiety and depressive disorders are marked).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  5. Respiratory capacity

    Measurement of chest expansion.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  6. Spinal and axial mobility (maximum active amplitudes - sagittal plane)

    Change in measurement of maximum active amplitudes in orthostatism of the thoraco-lumbar spine in the sagittal (flexion/extension) plane.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  7. Spinal and axial mobility (degrees of kyphosis and lordosis)

    Change in measurement of the degrees of kyphosis and lordosis while standing.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  8. Spinal and axial mobility (maximum active amplitudes - frontal plane)

    Change in measurement of maximum active amplitudes in orthostatism of the thoraco-lumbar spine in the frontal (lateral inclinations) plane.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  9. Spinal and axial mobility (podobarometric treadmill)

    Change in measurement of the spatiotemporal analysis of gait on a podobarometric treadmill.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  10. Axial mobility

    Change in BASMI (Bath Ankylosing Spondylitis Metrology Index) score (5 items, max score = 10, the higher the score the more restricted the axial mobility).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  11. Follow-up of the therapeutic strategy

    Change in therapeutic strategy.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  12. Drug consumption monitoring

    Change in drug consumption.

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  13. Sleep quality

    Change in QESL score (Leeds Sleep Assessment Questionnaire) (10 visual analog scales, minimum = -50, maximum = 50, the higher the score the better the sleep).

    Time frame: Between the 2 month visit and the 5 month visit. Between the 2 month visit and the 11 month visit.

  14. Adherence to the practice of yogatherapy of patients randomized in this group

    Degree of adherence to the practice of yogatherapy collected through responses to a short self-questionnaire.

    Time frame: After physical rehabilitation : at 5 month and 11 month visits.

07

Study locations

3 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Datas are own by Assistance Publique - Hôpitaux de Paris, please contact sponsor for further information.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2024 (actual). Primary completion is estimated for Feb 2028, 41 months after the start.

Of 46 non-industry interventional studies with no phase under Axial Spondyloarthritis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 42. This study's planned 41 months is above that.

Counting every sponsor, half of 46 studies reached it within 28 months; a quarter within 11 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 21, 2023
First posted
Oct 13, 2023
StartActual
Aug 27, 2024
Primary completionEst.
Feb 6, 2028
CompletionEst.
Aug 27, 2028
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06083090
Responsible party
Sponsor
First posted
Oct 13, 2023
Start date
Aug 27, 2024
Primary completion
Feb 6, 2028 (estimated)
Completion
Aug 27, 2028 (estimated)
Last update
Oct 1, 2025

Study contacts

Petra PAREJO MARGALLO
Contact
petri.parejo-margallo@aphp.fr
+33 1 40 27 43 13
Charlotte PAUWELS
Contact
charlotte.pauwels@aphp.fr
+33 1 49 81 30 66
Petra PAREJO MARGALLO
study director · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion